| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/17/2006 | CN1772039A Product of coromandel and method for its use |
| 05/17/2006 | CN1772029A Bitter gourd essence preparing process |
| 05/17/2006 | CN1772023A Refined angelica oil and its extraction process and prepn form |
| 05/17/2006 | CN1771996A Effervescent pearl tablet and its prepn |
| 05/17/2006 | CN1771987A Sodium diester alginate dripping pill and its prepn |
| 05/17/2006 | CN1771985A Application of chitin in preparing product for regulating body's acid-base equilibrium |
| 05/17/2006 | CN1771972A Clodronate liposome and its prepn |
| 05/17/2006 | CN1771968A Ursolic acid fat emulsion injection and its prepn |
| 05/17/2006 | CN1771957A Bilobalide-containing medicine composition and its prepn and use |
| 05/17/2006 | CN1771952A Gliquidone dripping pill and its prepn |
| 05/17/2006 | CN1771944A Application of high-solubility berberine in preparing medicine |
| 05/17/2006 | CN1771943A Novel method of treatment |
| 05/17/2006 | CN1771928A Application of EDTA or its salt in slimming medicine |
| 05/17/2006 | CN1771927A Calcium hydrophenyl sulfonate capsule and its prepn process |
| 05/17/2006 | CN1771924A New Western medicine prepn for treating type-II diabetes |
| 05/17/2006 | CN1771912A Orally taken nanometer protein polypetide composition particle and its prepn |
| 05/17/2006 | CN1256350C Water and oil soluble O-chitosan derivatives and their preparation and use |
| 05/17/2006 | CN1256337C Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza cyclopenta [A] naphthalene |
| 05/17/2006 | CN1256333C Method for synthesizing saturated fatty acid vitamin C ester |
| 05/17/2006 | CN1256314C Non-cyclic 1,3-dicarbonyl PPAR double-activation compound with sugar-reducing lipid-reducing activity and preparation method of its medicinal preparation |
| 05/17/2006 | CN1256139C Chinese medicinal preparation for lowering viscosity and preventing embolism |
| 05/17/2006 | CN1256112C Chinese traditional medicine preparation for treating cardiac and cerebral vascular diseases and its preparation process |
| 05/17/2006 | CN1256108C Ass-hide glue phosphotipid composition and its preparing method |
| 05/17/2006 | CN1256106C Medicinally health-care powder made of ganoderma and lentinan |
| 05/17/2006 | CN1256098C Process for preparing livestock animal brain fat composite medicine |
| 05/17/2006 | CN1256097C Yak-blood deproteined extract and its extraction method and use thereof |
| 05/17/2006 | CN1256094C 3'-Deoxyadenosine in application of preparing bypolipidemic |
| 05/17/2006 | CN1256088C 维生素c钠胶囊 Vitamin c sodium capsules |
| 05/17/2006 | CN1256085C Sertraline salts and substained-release dosage forms of sertraline |
| 05/17/2006 | CN1256082C Slow-released preparation |
| 05/17/2006 | CN1256043C Method for producing oyster tablet by adding oyster shell superfine powder |
| 05/17/2006 | CN1256029C Use of food as delevery system for phytase in humans |
| 05/16/2006 | US7045683 Δ4-desaturase genes and uses thereof |
| 05/16/2006 | US7045665 substituted benzylphenol derivatives as intermediates for glucopyranosyloxybenzylbenzene derivatives; agents for the prevention or treatment of diabetes, diabetic complications, obesity or the like |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045649 compounds are suitable, for example, for use as anorectics |
| 05/16/2006 | US7045636 MCH antagonists for the treatment of obesity |
| 05/16/2006 | US7045633 Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| 05/16/2006 | US7045631 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 05/16/2006 | US7045591 Cyclic peptide for use in the treatment of eating disorders |
| 05/16/2006 | US7045546 Stabilized derivatives of ascorbic acid-3-phosphate |
| 05/16/2006 | US7045541 Compounds for the treatment of metabolic disorders |
| 05/16/2006 | US7045540 Selective estrogen receptor modulators |
| 05/16/2006 | US7045529 Imidazopyrimidinyl and imidazopyri dinyl derivatives |
| 05/16/2006 | US7045528 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 05/16/2006 | US7045526 Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them |
| 05/16/2006 | US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field |
| 05/16/2006 | US7045520 Opioid receptor active compounds |
| 05/16/2006 | US7045517 Triazine compounds |
| 05/16/2006 | US7045515 Anticholesterol agents |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045502 Administering concurrent with cell grafting surgery using insulin producing stem cells |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045346 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 05/16/2006 | US7045299 Digestive diseases; amino acid sequence 20 or 21; specific to orphan receptor protein ZAQ |
| 05/16/2006 | US7045155 Phytooestrogen selected from genistein, daidzein; for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia |
| 05/16/2006 | US7045148 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 05/16/2006 | US7045146 Treating the solid particle material with an amphiphilic substance and coating the material with a layer of a charged polyelectrolyte or with a multilayer comprising alternating layers of oppositely charged polyelectrolytes. |
| 05/16/2006 | US7045143 Mixture of lecithin and fatty acid; antiinflammatory agents; diseases of lipid metabolism; immunology disorders |
| 05/16/2006 | CA2291650C Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/11/2006 | WO2006050432A1 Methods for regulating weight and size of animals with glycin |
| 05/11/2006 | WO2006050314A2 Once a day formulation for phosphate binders |
| 05/11/2006 | WO2006050212A1 Substituted carboxylic acids |
| 05/11/2006 | WO2006050126A1 Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of obesity |
| 05/11/2006 | WO2006050097A1 Substituted phenylalkanoic acids |
| 05/11/2006 | WO2006049952A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/11/2006 | WO2006049880A1 Tetrahydro pyridinyl pyrazole cannabinoid modulators |
| 05/11/2006 | WO2006049304A1 Aryloxy-substituted benzimidazole derivatives |
| 05/11/2006 | WO2006049234A1 Peroxisome proliferator-activated receptor (ppar) activator and drug, supplement, functional food and food additive using the same |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | WO2006048894A1 Novel crystalline forms of atorvastatin calcium and processes for preparing them. |
| 05/11/2006 | WO2006048331A1 11β-HSD1 INHIBITORS |
| 05/11/2006 | WO2006048330A1 11βετα-hsd1 inhibitors |
| 05/11/2006 | WO2006048208A1 Bilayer tablet comprising telmisartan and amlodipine |
| 05/11/2006 | WO2006034463A3 Herbal supplement to support weight loss |
| 05/11/2006 | WO2006018450A3 Pharmaceutically active insulin receptor-modulating molecules |
| 05/11/2006 | WO2006018280A3 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 05/11/2006 | WO2006018279A3 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 05/11/2006 | WO2006018019A3 SELECTIVE INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 05/11/2006 | WO2005106471A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 4 (ccr4) |
| 05/11/2006 | WO2005089731A3 Use of renin inhibitors in therapy |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | US20060100446 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100445 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100283 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 05/11/2006 | US20060100278 Dosage forms and related therapies |
| 05/11/2006 | US20060100267 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100255 Substituted indolealkanoic acids derivative and formulations containing same for use in the treatment of diabetic complications |
| 05/11/2006 | US20060100247 Treatment of diabetes with thiazolidinedione and metformin |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100230 Indolin phenylsulfonamide derivatives |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100199 Novel condensed imidazole derivatives |
| 05/11/2006 | US20060100177 Stabilized ascorbic acid derivatives |
| 05/11/2006 | US20060100172 Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes |
| 05/11/2006 | US20060100171 Branched alpha-glucans for weight management |
| 05/11/2006 | US20060100166 Compounds for modulating the activity of exchange proteins directly activated by camp (epacs) |
| 05/11/2006 | US20060100145 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |